All In Biotech

Drug Trial Radar · NCT06937086

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 350 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

Jun 26, 2025

Primary completion

Apr 2028

Study completion Apr 2028

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Apr 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disappearance of UC symptoms, and loss of at least one-tenth of the overall body weight. Participation in this study will last up to 61 weeks, including 52 weeks of treatment.

Conditions

  • Ulcerative Colitis
  • Obesity or Overweight

Interventions

  • MirikizumabDrug

    Administered IV

  • MirikizumabDrug

    Administered SC

  • TirzepatideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Simultaneously Achieve Clinical Remission and at Least 10% Weight ReductionTime frame: Week 52

Locations

186 sites in 23 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists

    Dothan, Alabama · Recruiting

  • Smart Cures Clinical Research

    Anaheim, California · Recruiting

  • Cedars-Sinai Medical Center

    Beverly Hills, California · Recruiting

  • United Medical Doctors - Los Alamitos

    Los Alamitos, California · Recruiting

  • California Medical Research Associates

    Northridge, California · Recruiting

  • Research Associates of South Florida - Miami - Southwest 8th Street

    Miami, Florida · Recruiting

  • Gastro Health Research - Miami

    Miami, Florida · Recruiting

  • Orlando Health

    Orlando, Florida · Recruiting

  • Digestive and Liver Center of Florida

    Orlando, Florida · Recruiting

  • Gastro Health Research - Pensacola

    Pensacola, Florida · Recruiting

  • Precision Clinical Research

    Sunrise, Florida · Recruiting

  • Grand Teton Research Group

    Idaho Falls, Idaho · Recruiting

  • Rush University Medical Center

    Chicago, Illinois · Recruiting

  • Indiana University Health University Hospital

    Indianapolis, Indiana · Recruiting

  • Gastroenterology Health Partners

    New Albany, Indiana · Recruiting

  • Gastroenterology Health Partners

    Louisville, Kentucky · Recruiting

  • Care Access - New Iberia

    New Iberia, Louisiana · Recruiting

  • Louisiana Research Center

    Shreveport, Louisiana · Recruiting

  • Capital Digestive Care - Chevy Chase

    Chevy Chase, Maryland · Recruiting

  • Lucida Clinical Trials

    New Bedford, Massachusetts · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Recruiting

  • Icahn School of Medicine at Mount Sinai

    New York, New York · Recruiting

  • New York Gastroenterology Associates

    New York, New York · Recruiting

  • Care Access - Yonkers

    Yonkers, New York · Recruiting

  • Coastal Research Institute - Fayetteville

    Fayetteville, North Carolina · Recruiting

  • Gastro Intestinal Research Institute of Northern Ohio, LLC

    Westlake, Ohio · Recruiting

  • Thomas Jefferson University - Medicine/GI and Hepatology

    Philadelphia, Pennsylvania · Recruiting

  • University Gastroenterology

    Providence, Rhode Island · Recruiting

  • Gastroenterology Associates - Patewood

    Greenville, South Carolina · Recruiting

  • Gastroenterology Center Of The Midsouth

    Cordova, Tennessee · Recruiting

  • Gastroenterology Research of San Antonio

    San Antonio, Texas · Recruiting

  • Southern Star Research Institute

    San Antonio, Texas · Recruiting

  • Tyler Research Institute

    Tyler, Texas · Recruiting

  • Gastroenterology Consultants of Southwest Virginia

    Roanoke, Virginia · Recruiting

  • Washington Gastroenterology - Tacoma

    Tacoma, Washington · Recruiting

  • Wisconsin Center for Advanced Research

    Milwaukee, Wisconsin · Recruiting

  • Medizinische Universität Graz

    Graz, Austria · Recruiting

  • Medizinische Universitaet Innsbruck

    Innsbruck, Austria · Recruiting

  • Medizinische Universität Wien

    Vienna, Austria · Recruiting

Showing 40 of 186 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.